FDA panel: keep COX-2 drugs on market: black box for COX-2 labels, caution urged for all NSAIDs.
Kuehn
Bridget M
BM
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004348:Drug Labeling; D014481:United States; D014486:United States Food and Drug Administration
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors